Captrust Financial Advisors Biolife Solutions Inc Transaction History

Captrust Financial Advisors

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$17.19 - $24.34 $2,234 - $3,164	130 Added 1.31%	10,059 $222,000
Q1 2023 May 15, 2023	BUY	$17.67 - $26.07 $175,445 - $258,849	9,929 New	9,929 $215,000
Q3 2022 Nov 16, 2022	BUY	$14.64 - $26.7 $79,041 - $144,153	5,399 Added 136.72%	9,348 $213,000
Q2 2022 Aug 23, 2022	SELL	$10.54 - $24.2 $65,400 - $150,161	-6,205 Reduced 61.11%	3,949 $55,000
Q2 2022 Aug 16, 2022	BUY	$10.54 - $24.2 $101,911 - $233,989	9,669 Added 1993.61%	10,154 $140,000
Q1 2022 May 16, 2022	BUY	$20.81 - $37.29 $1,872 - $3,356	90 Added 22.78%	485 $11,000
Q4 2021 Feb 14, 2022	SELL	$32.99 - $58.55 $7,125 - $12,646	-216 Reduced 35.35%	395 $15,000
Q3 2021 Nov 16, 2021	BUY	$42.03 - $60.5 $2,731 - $3,932	65 Added 11.9%	611 $26,000
Q2 2021 Aug 16, 2021	BUY	$29.51 - $44.62 $8,498 - $12,850	288 Added 111.63%	546 $24,000
Q3 2020 Nov 17, 2020	SELL	$16.04 - $28.94 $4,010 - $7,235	-250 Reduced 49.21%	258 $8,000
Q2 2020 Aug 14, 2020	BUY	$9.2 - $17.06 $4,673 - $8,666	508 New	508 $8,000

199

45M

8.2K

Ticker BLFS
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 42,684,400
Market Cap $1.11B
Description
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.